Efficacy and safety of transarterial chemoembolization combined with lenvatinib and camrelizumab in patients with BCLC-defined stage C hepatocellular carcinoma

OBJECTIVE: To investigate the effectiveness and safety of combining transarterial chemoembolization (TACE) with lenvatinib and camrelizumab in patients with Barcelona Clinic Liver Cancer (BCLC) stage C hepatocellular carcinoma (HCC). METHODS: We retrospectively analyzed 141 patients with BCLC stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Juan, Zeng, Jia, Wang, Huiwen, Huo, Zhuoni, Hou, Xunbo, He, Dongfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616839/
https://www.ncbi.nlm.nih.gov/pubmed/37916160
http://dx.doi.org/10.3389/fonc.2023.1244341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616839/
https://www.ncbi.nlm.nih.gov/pubmed/37916160
http://dx.doi.org/10.3389/fonc.2023.1244341

Ejemplares similares